Literature DB >> 28513453

Chronic obstructive pulmonary disease.

Klaus F Rabe1, Henrik Watz2.   

Abstract

Chronic obstructive pulmonary disease (COPD) kills more than 3 million people worldwide every year. Despite progress in the treatment of symptoms and prevention of acute exacerbations, few advances have been made to ameliorate disease progression or affect mortality. A better understanding of the complex disease mechanisms resulting in COPD is needed. Smoking cessation programmes, increasing physical activity, and early detection and treatment of comorbidities are further key components to reduce the burden of the disease. However, without a global political and economic effort to reduce tobacco use, to regulate environmental exposure, and to find alternatives to the massive use of biomass fuel, COPD will remain a major health-care problem for decades to come.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28513453     DOI: 10.1016/S0140-6736(17)31222-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  232 in total

Review 1.  The Pediatric Cell Atlas: Defining the Growth Phase of Human Development at Single-Cell Resolution.

Authors:  Deanne M Taylor; Bruce J Aronow; Kai Tan; Kathrin Bernt; Nathan Salomonis; Casey S Greene; Alina Frolova; Sarah E Henrickson; Andrew Wells; Liming Pei; Jyoti K Jaiswal; Jeffrey Whitsett; Kathryn E Hamilton; Sonya A MacParland; Judith Kelsen; Robert O Heuckeroth; S Steven Potter; Laura A Vella; Natalie A Terry; Louis R Ghanem; Benjamin C Kennedy; Ingo Helbig; Kathleen E Sullivan; Leslie Castelo-Soccio; Arnold Kreigstein; Florian Herse; Martijn C Nawijn; Gerard H Koppelman; Melissa Haendel; Nomi L Harris; Jo Lynne Rokita; Yuanchao Zhang; Aviv Regev; Orit Rozenblatt-Rosen; Jennifer E Rood; Timothy L Tickle; Roser Vento-Tormo; Saif Alimohamed; Monkol Lek; Jessica C Mar; Kathleen M Loomes; David M Barrett; Prech Uapinyoying; Alan H Beggs; Pankaj B Agrawal; Yi-Wen Chen; Amanda B Muir; Lana X Garmire; Scott B Snapper; Javad Nazarian; Steven H Seeholzer; Hossein Fazelinia; Larry N Singh; Robert B Faryabi; Pichai Raman; Noor Dawany; Hongbo Michael Xie; Batsal Devkota; Sharon J Diskin; Stewart A Anderson; Eric F Rappaport; William Peranteau; Kathryn A Wikenheiser-Brokamp; Sarah Teichmann; Douglas Wallace; Tao Peng; Yang-Yang Ding; Man S Kim; Yi Xing; Sek Won Kong; Carsten G Bönnemann; Kenneth D Mandl; Peter S White
Journal:  Dev Cell       Date:  2019-03-28       Impact factor: 12.270

2.  IL-33 induces production of autoantibody against autologous respiratory epithelial cells: a potential mechanism for the pathogenesis of COPD.

Authors:  Qin Li; Yue Hu; Yan Chen; Zhe Lv; Jingjing Wang; Gao An; Xiaonan Du; Huating Wang; Chris J Corrigan; Wei Wang; Sun Ying
Journal:  Immunology       Date:  2019-03-27       Impact factor: 7.397

Review 3.  Crosstalk Between Lung and Extrapulmonary Organs in Infection and Inflammation.

Authors:  Zhihan Wang; Qinqin Pu; Canhua Huang; Min Wu
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Automated MR-based lung volume segmentation in population-based whole-body MR imaging: correlation with clinical characteristics, pulmonary function testing and obstructive lung disease.

Authors:  Jan Mueller; Stefan Karrasch; Roberto Lorbeer; Tatyana Ivanovska; Andreas Pomschar; Wolfgang G Kunz; Ricarda von Krüchten; Annette Peters; Fabian Bamberg; Holger Schulz; Christopher L Schlett
Journal:  Eur Radiol       Date:  2018-08-27       Impact factor: 5.315

5.  Long noncoding RNAs antisense noncoding RNA in the INK4 locus (ANRIL) correlates with lower acute exacerbation risk, decreased inflammatory cytokines, and mild GOLD stage in patients with chronic obstructive pulmonary disease.

Authors:  Jianli Ge; Shasha Geng; Hua Jiang
Journal:  J Clin Lab Anal       Date:  2018-09-19       Impact factor: 2.352

6.  Smokers with COPD Show a Shift in Energy and Nitrogen Metabolism at Rest and During Exercise.

Authors:  Olaf Holz; David S DeLuca; Stefan Roepcke; Thomas Illig; Klaus M Weinberger; Christian Schudt; Jens M Hohlfeld
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-06

7.  Dysregulation of the glutaredoxin/S-glutathionylation redox axis in lung diseases.

Authors:  Shi B Chia; Evan A Elko; Reem Aboushousha; Allison M Manuel; Cheryl van de Wetering; Joseph E Druso; Jos van der Velden; David J Seward; Vikas Anathy; Charles G Irvin; Ying-Wai Lam; Albert van der Vliet; Yvonne M W Janssen-Heininger
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-06       Impact factor: 4.249

8.  Update in Chronic Obstructive Pulmonary Disease 2017.

Authors:  William Z Zhang; Kazunori Gomi; Seyed Babak Mahjour; Fernando J Martinez; Renat Shaykhiev
Journal:  Am J Respir Crit Care Med       Date:  2018-06-15       Impact factor: 21.405

Review 9.  Stem cell therapy for COVID-19 and other respiratory diseases: Global trends of clinical trials.

Authors:  Hong-Long Ji; Cong Liu; Run-Zhen Zhao
Journal:  World J Stem Cells       Date:  2020-06-26       Impact factor: 5.326

10.  Respiration-related guidance and nursing can improve the respiratory function and living ability of elderly patients with chronic obstructive pulmonary disease.

Authors:  Xiaoyan Sun; Yu Shen; Jian Shen
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.